Clever Leaves is a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts.
Clever Leaves is on a mission to operate in compliance with federal and state laws and with an emphasis on ecologically sustainable, large-scale cultivation and processing as the cornerstones of its global cannabis business.
Clever Leaves was founded in 2016 and is headquartered in New York, New York, with offices in Canada, Colombia, Germany, Portugal.
Clever Leaves is a leading vertically integrated producer of medical cannabis and hemp extracts and is currently cultivating over 1.8 million square feet of greenhouses under Good Agricultural and Collection Practices (GACP) in Colombia.
Clever Leaves’ first extraction facility is currently capable of extracting 2,400 kilograms of dried flower per month, with expansion underway to increase expected extraction capacity to 9,000 kilograms of dried flower per month by mid-2020.
Clever Leaves is backed by completed first closing and Raised $14M in Series E Financing on April 14, 2020. This brings Clever Leaves' total funding to $120M to date.